Your browser doesn't support javascript.
loading
Specific cytotoxic T-cell immune responses against autoantigens recognized by chronic lymphocytic leukaemia cells.
Zaleska, Joanna; Skorka, Katarzyna; Zajac, Malgorzata; Karczmarczyk, Agnieszka; Karp, Marta; Tomczak, Waldemar; Hus, Marek; Wlasiuk, Paulina; Giannopoulos, Krzysztof.
Afiliação
  • Zaleska J; Department of Experimental Haemato-oncology, Medical University of Lublin, Lublin, Poland.
  • Skorka K; Department of Experimental Haemato-oncology, Medical University of Lublin, Lublin, Poland.
  • Zajac M; Department of Experimental Haemato-oncology, Medical University of Lublin, Lublin, Poland.
  • Karczmarczyk A; Department of Experimental Haemato-oncology, Medical University of Lublin, Lublin, Poland.
  • Karp M; Department of Experimental Haemato-oncology, Medical University of Lublin, Lublin, Poland.
  • Tomczak W; Postgraduate School of Molecular Medicine, Warsaw, Poland.
  • Hus M; Department of Haemato-oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
  • Wlasiuk P; Department of Haemato-oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
  • Giannopoulos K; Department of Experimental Haemato-oncology, Medical University of Lublin, Lublin, Poland.
Br J Haematol ; 174(4): 582-90, 2016 08.
Article em En | MEDLINE | ID: mdl-27097566
ABSTRACT
Mounting evidence suggests that autoreactivity and inflammatory processes are involved in the pathogenesis of chronic lymphocytic leukaemia (CLL). Cytoskeletal proteins, including non-muscle myosin heavy chain IIA (MYHIIA), vimentin (VIM) and cofilin-1 (CFL1), exposed on the surface of apoptotic cells have been identified as autoantigens that are recognized by the specific B-cell receptors of the CLL cells. In 212 CLL patients analysed with quantitative reverse transcriptase-polymerase chain reaction we found CFL1 overexpression and low expression of MYH9 in comparison with healthy volunteers. We detected specific cytotoxic immune responses for peptides derived from MYHIIA in 66·7%, VIM in 87·5% and CFL1 in 62·5% CLL patients in an Enzyme-Linked ImmunoSpot assay. Low frequencies of autoreactive peptide-specific T cells were detected against MYHIIA, VIM and CFL1 in CLL patients ex vivo; most of the detected cells had an effector-memory phenotype. Our findings support the existence of cytotoxic immune responses against three autoantigens that have been identified as targets of CLL clonotypic B-cell receptors. The presence of autoreactive CD8(+) T cells against MYHIIA, VIM and CFL1 in CLL patients indicates the involvement of antigen-specific autoreactive T cells in the pathogenesis of CLL.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoantígenos / Linfócitos T Citotóxicos / Leucemia Linfocítica Crônica de Células B Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoantígenos / Linfócitos T Citotóxicos / Leucemia Linfocítica Crônica de Células B Idioma: En Ano de publicação: 2016 Tipo de documento: Article